Genotype Single Infection Single % Multiple Infection Multiple % Total Total % 6 20 4.00 10 2.00 30 6.00 9 1 0.20 0 0.00 1 0.20 11 1 0.20 0 0.00 1 0.20 16 59 11.80 33 6.60 92 18.40 18 13 2.60 11 2.20 24 4.80 31 11 2.20 6 1.20 17 3.40 33 6 1.20 7 1.40 13 2.60 35 3 0.60 2 0.40 5 1.00 39 7 1.40 1 0.20 8 1.60 40 1 0.20 2 0.40 3 0.60 42 4 0.80 2 0.40 6 1.20 45 9 1.80 5 1.00 14 2.80 51 21 4.20 17 3.40 38 7.60 52 28 5.60 22 4.40 50 10.00 53 16 3.20 9 1.80 25 5.00 54 6 1.20 10 2.00 16 3.20 55 1 0.20 3 0.60 4 0.80 56 5 1.00 0 0.00 5 1.00 58 14 2.80 8 1.60 22 4.40 59 17 3.40 10 2.00 27 5.40 61 13 2.60 11 2.20 24 4.80 62 12 2.40 3 0.60 15 3.00 66 5 1.00 5 1.00 10 2.00 67 2 0.40 1 0.20 3 0.60 68 3 0.60 0 0.00 3 0.60 69 1 0.20 0 0.00 1 0.20 70 3 0.60 2 0.40 5 1.00 71 3 0.60 0 0.00 3 0.60 72 5 1.00 2 0.40 7 1.40 73 4 0.80 0 0.00 4 0.80 81 5 1.00 0 0.00 5 1.00 83 3 0.60 3 0.60 6 1.20 84 4 0.80 5 1.00 9 1.80 CP6108 2 0.40 1 0.20 3 0.60 IS39 1 0.20 0 0.00 1 0.20 Total 309 61.80 191 38.20 500 100

Table 2: Human Papilloma Virus (HPV) genotyping of single or multiple infections in 309 women with detectable HPV DNA. Percentage is calculated with respect to totalized 500 positive HPV ID’s.